CollPlant Receives Governmental Authorization for R&D Projects

CollPlant received authorization from the Chief Scientist of Israel's Ministry of Economy for funding ~50% of its NIS 12MM (~US $3.1MM) development project for 2016.

Funds will support development of products to treat torn tendons/ligaments, as well as final development of Vergenix™STR to treat inflamed tendons, for which the company is...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us